Market Overview
Blood transfusion is the procedure of transferring blood to the frame. Transfusions are used for diverse medical situations to update lost components of the blood.
Blood transfusions are completed to update blood misplaced during surgery or due to severe harm. A transfusion also may be completed if the body can’t make blood well due to contamination.
Blood transfusions are very not unusual; almost Five million people get hold of a blood transfusion each year within the U.S.
Download free sample @ https://bit.ly/3sYylEv
Market Dynamics
The growing occurrence of blood most cancers is one of the elements fueling the global transfusion diagnostics marketplace.
According to the Leukemia Research Foundation, in 2018, greater than 201,870 new cases of blood cancer are predicted within the United States. Approximately 387,000 Americans are living with leukemia.
According to Cancer Research UK, there are around nine,900 new leukemia cases in the UK each yr. Leukemia is the twelfth maximum common most cancers inside the UK, accounting for 3% of all new cancer instances. In 2015, leukemia became the tenth maximum not unusual cancer in males with around 5,900 new instances in the U.K, and twelfth most commonplace most cancers within the girl, with about 4,000 new cases in the U.K.
Market Segmentation
BY TYPE
l Instruments & Kit
l Reagents
l Others
BY APPLICATION
l Blood grouping
l Disease screening
l Others
END USER
l Hospitals
l Laboratories
l Blood banks
l Plasma fractionation facilities
l Others
By Region
l North America
l Europe
l South America
l Asia-Pacific
l Middle East and Africa
View full report @ https://bit.ly/3Ku28uw
Competitive Analysis
The regulatory approval, a strategic alliance between companies and the launch of new diagnostics, is one of the critical factor driving the global transfusion diagnostics market.
In January 2019, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, has received approval by Health Canada for its fully automated Echo instrument, Echo Lumena, designed for the small to mid-volume laboratory segment, is Immucor’s fifth-generation immunohematology instrument and brings brilliant performance and more unambiguous test results.
In June 2017, Grifols, and Beckman Coulter Inc. entered into an exclusive, long-term agreement for the global distribution of Grifols’ hemostasis instruments, reagents, and consumables.
Trending Topic’s
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/transfusion-diagnostics-market